Gouyette A - Search Results

1

Phase I-II and pharmacokinetic study of a new fotemustine schedule in advanced non-small cell lung cancer.

Le Cesne A, Chabot G, Bérille J, Lucas C, Baud M, Gouyette A, Marty M, Le Chevalier T. Le Cesne A, et al. Among authors: gouyette a. Lung Cancer. 1995 Aug;13(1):69-78. doi: 10.1016/0169-5002(95)00479-k. Lung Cancer. 1995. PMID: 8528641 Clinical Trial.

2

Phase I and pharmacokinetic study of the camptothecin derivative irinotecan, administered on a weekly schedule in cancer patients.

de Forni M, Bugat R, Chabot GG, Culine S, Extra JM, Gouyette A, Madelaine I, Marty ME, Mathieu-Boué A. de Forni M, et al. Among authors: gouyette a. Cancer Res. 1994 Aug 15;54(16):4347-54. Cancer Res. 1994. PMID: 8044782 Clinical Trial.

3

Main drug- and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissues.

Toussaint C, Albin N, Massaad L, Grunenwald D, Parise O Jr, Morizet J, Gouyette A, Chabot GG. Toussaint C, et al. Among authors: gouyette a. Cancer Res. 1993 Oct 1;53(19):4608-12. Cancer Res. 1993. PMID: 8402635

4

Phase II and pharmacokinetic study of fotemustine in inoperable colorectal cancer.

Rougier P, Chabot GG, Bonneterre J, Tigaud JM, Lucas C, Baud M, Bérille J, Gouyette A. Rougier P, et al. Among authors: gouyette a. Eur J Cancer. 1993;29A(2):288-9. doi: 10.1016/0959-8049(93)90200-y. Eur J Cancer. 1993. PMID: 8422301 Clinical Trial. No abstract available.

5

Pharmacokinetic and pharmacodynamic advantages of pirarubicin over adriamycin after intraarterial hepatic administration in the rabbit VX2 tumor model.

Munck JN, Riggi M, Rougier P, Chabot GG, Ramirez LH, Zhao Z, Bognel C, Ardouin P, Herait P, Gouyette A. Munck JN, et al. Among authors: gouyette a. Cancer Res. 1993 Apr 1;53(7):1550-4. Cancer Res. 1993. PMID: 8453622

6

Phase I and pharmacokinetic study of brequinar (DUP 785; NSC 368390) in cancer patients.

de Forni M, Chabot GG, Armand JP, Fontana X, Recondo G, Domenge C, Carde P, Barbu M, Gouyette A. de Forni M, et al. Among authors: gouyette a. Eur J Cancer. 1993;29A(7):983-8. doi: 10.1016/s0959-8049(05)80206-0. Eur J Cancer. 1993. PMID: 8499153 Clinical Trial.

7

[High-doses chemotherapy followed by bone marrow autograft in the treatment of small cell bronchial cancer].

Pico JL, Baume D, Ostronoff M, Beaujean F, Gouyette A, Le Chevalier T, Arriagada R, Rebattu P, Hayat M. Pico JL, et al. Among authors: gouyette a. Bull Cancer. 1987;74(5):587-95. Bull Cancer. 1987. PMID: 2825862 French.

8

Phase I and pharmacology study of flavone acetic acid administered two or three times weekly without alkalinization.

de Forni M, Chabot GG, Armand JP, Gouyette A, Klink-Alak M, Recondo G. de Forni M, et al. Among authors: gouyette a. Cancer Chemother Pharmacol. 1995;35(3):219-24. doi: 10.1007/BF00686551. Cancer Chemother Pharmacol. 1995. PMID: 7805180 Clinical Trial.

9

Flavone acetic acid (LM-975; NSC-347512) activation to cytotoxic species in vivo and in vitro.

Chabot GG, Bissery MC, Gouyette A. Chabot GG, et al. Among authors: gouyette a. Cancer Chemother Pharmacol. 1989;24(5):273-6. doi: 10.1007/BF00304757. Cancer Chemother Pharmacol. 1989. PMID: 2758556

10

Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients.

Abigerges D, Chabot GG, Armand JP, Hérait P, Gouyette A, Gandia D. Abigerges D, et al. Among authors: gouyette a. J Clin Oncol. 1995 Jan;13(1):210-21. doi: 10.1200/JCO.1995.13.1.210. J Clin Oncol. 1995. PMID: 7799022 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters